A Double–Blind Controlled Clinical Trial of Haloperidol Decanoate and Fluphenazine Decanoate in the Maintenance Treatment of Schizophrenia
In recent years the use of long-acting injectable neuroleptics in the maintenance treatment of schizophrenia has become increasingly common. Initial open studies carried out in schizophrenic inpatients have confirmed that the new depot neuroleptic, haloperidol decanoate, has antipsychotic properties (Deberdt et al., 1980; Suarez Richards et al., 1982; Viukari et al., 1982). A double-blind controlled study was carried out to compare the efficacy of haloperidol decanoate to fluphenazine decanoate in the maintenance treatment of schizophrenic outpatients.
KeywordsMaintenance Treatment Tardive Dyskinesia Brief Psychiatric Rate Scale Haloperidol Decanoate Fluphenazine Decanoate
Unable to display preview. Download preview PDF.
- 4.Suarez Richards M, Actis Data AC, Zelaschi NM, et al., Monthly haloperidol decanoate substitutes for daily neuroleptics in psychotic inpatients. Curr Ther Res 32: 586–589, 1982.Google Scholar